Research ArticleTUMOR IMMUNOLOGY

IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer

See allHide authors and affiliations

Science Immunology  17 Apr 2020:
Vol. 5, Issue 46, eaav3942
DOI: 10.1126/sciimmunol.aav3942

Log in to view PDF

Log in through your institution

Log in through your institution

Stay Connected to Science Immunology